E
Evi Lianidou
Researcher at National and Kapodistrian University of Athens
Publications - 203
Citations - 8268
Evi Lianidou is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Circulating tumor cell & Cancer. The author has an hindex of 50, co-authored 181 publications receiving 7035 citations. Previous affiliations of Evi Lianidou include Toronto Western Hospital.
Papers
More filters
Journal ArticleDOI
Prognostic Value of Mature MicroRNA-21 and MicroRNA-205 Overexpression in Non–Small Cell Lung Cancer by Quantitative Real-Time RT-PCR
Athina Markou,Emily Tsaroucha,Loukas Kaklamanis,Marianthi Fotinou,Vassilis Georgoulias,Evi Lianidou +5 more
TL;DR: It is suggested that overexpression of mature miR-21 is an independent negative prognostic factor for OS in NSCLC patients.
Journal ArticleDOI
Predictive and Prognostic Value of Peripheral Blood Cytokeratin-19 mRNA-Positive Cells Detected by Real-Time Polymerase Chain Reaction in Node-Negative Breast Cancer Patients
N. Xenidis,M. Perraki,Maria Kafousi,Stella Apostolaki,Irene Bolonaki,Aliki Stathopoulou,Kostas Kalbakis,Nikos Androulakis,Charalambos Kouroussis,Thanos Pallis,Charalambos Christophylakis,Katerina Argyraki,Evi Lianidou,Stathis Stathopoulos,Vassilis Georgoulias,Dimitris Mavroudis +15 more
TL;DR: In this paper, the authors evaluated the predictive and prognostic value of peripheral blood cytokeratin-19 (CK-19) mRNA-positive cells in axillary lymph node-negative breast cancer patients.
Journal ArticleDOI
Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer
Nikolaos Xenidis,Michail Ignatiadis,Stella Apostolaki,M. Perraki,Kostas Kalbakis,Sofia S. Agelaki,Efstathios N. Stathopoulos,Grigorios Chlouverakis,Evi Lianidou,S. Kakolyris,Vassilis Georgoulias,Dimitris Mavroudis +11 more
TL;DR: The detection of CK-19 mRNA-positive CTCs in the blood after adjuvant chemotherapy is an independent risk factor indicating the presence of chemotherapy-resistant residual disease.
Journal ArticleDOI
Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer
Michail Ignatiadis,Galatea Kallergi,Maria Ntoulia,M. Perraki,Stella Apostolaki,Maria Kafousi,Grigorios Chlouverakis,Efstathios N. Stathopoulos,Evi Lianidou,Vassilis Georgoulias,Dimitris Mavroudis +10 more
TL;DR: The detection of peripheral blood CK19mRNA+ and MGB1m RNA+ cells before adjuvant chemotherapy predicts poor DFS in women with early breast cancer.
Journal ArticleDOI
Different Prognostic Value of Cytokeratin-19 mRNA–Positive Circulating Tumor Cells According to Estrogen Receptor and HER2 Status in Early-Stage Breast Cancer
Michail Ignatiadis,N. Xenidis,M. Perraki,Stella Apostolaki,Eleni Politaki,Maria Kafousi,Efstathios N. Stathopoulos,Aliki Stathopoulou,Evi Lianidou,Grigorios Chlouverakis,Christos Sotiriou,Vassilis Georgoulias,Dimitris Mavroudis +12 more
TL;DR: In multivariate analysis, the interaction between CK-19 mRNA-positive CTCs and ER status was the strongest independent prognostic factor for reduced DFS and overall survival in patients with ER- negative, triple-negative, and HER2-positive early-stage breast cancer.